However, tumor-derived cytokines and growth factors, notably IL-10, VEGF, and TGF-β, can skew DC differentiation toward a tolerogenic phenotype characterized by reduced expression of costimulatory molecules, impaired antigen presentation, and increased secretion of immunosuppressive cytokines (29–31). The gene discussed is VEGFA; the disease is neoplasm.